World's Best Scientists 2026 revealed!
Anthony C. Keech

Anthony C. Keech

D-Index & Metrics

Medicine

D-Index
96
Citations
78507
World Ranking
9450
National Ranking
288

Overview

Anthony C. Keech is affiliated with the University of Sydney in Australia and has a substantial body of research primarily in the field of medicine. Their work spans several subfields including surgery, endocrinology, diabetes and metabolism, cardiology and cardiovascular medicine, economics and econometrics, and genetics.

The main areas of study for this scientist are diverse, with particular emphasis on lipoproteins and cardiovascular health, health systems, economic evaluations and quality of life, diabetes management and research, pancreatic function and diabetes, atherosclerosis and cardiovascular diseases, diabetes intertwined with cardiovascular risks and lipoproteins, as well as cardiac valve diseases and treatments.

Frequent venues for publication include leading medical journals and specialized outlets, reflecting the broad scope of their research topics. These venues are:

  • Circulation
  • Heart Lung and Circulation
  • Journal of the American College of Cardiology
  • Diabetes
  • Internal Medicine Journal

Among their recent papers are the following, which highlight key aspects of their research focus and collaboration:

  • "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease" (2022), published in Circulation
  • "Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial" (2020), published in The Lancet Diabetes & Endocrinology
  • "Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials" (2020), published in The Lancet
  • "Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials" (2021), published in European Heart Journal
  • "Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials" (2022), published in The Lancet

Collaborative work is an important aspect of their scientific contributions, with frequent co-authors including:

  • Alicia J. Jenkins
  • Marc S. Sabatine
  • Robert P. Giugliano
  • Andrzej S. Januszewski
  • Rachel O'Connell

Throughout their career, Anthony C. Keech has contributed extensively to the understanding of complex interactions in cardiovascular and metabolic diseases, combining clinical research with broader economic and health systems perspectives. Their publication record spans over 286 works in medicine, indicating an active and sustained research trajectory.

Best Publications

  • Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

    C Baigent;A Keech;P M Kearney;L Blackwell

  • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

    A. Tonkin;P. Alyward;D. Colquhoun;P. Glasziou

  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

    C Baigent;L Blackwell;J Emberson

  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    Marc S. Sabatine;Robert P. Giugliano;Anthony C. Keech;Narimon Honarpour

  • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

    A Keech;R J Simes;P Barter;J Best

  • The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials

    B Mihaylova;J Emberson;L Blackwell

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

    P M Kearney;L Blackwell;R Collins

  • Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials

    J Fulcher;R O'Connell;M Voysey

  • Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

    AC Keech;AC Keech;P Mitchell;PA Summanen;J O'Day

  • ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

    R Collins;R Peto;M Flather;S Parish

  • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

    J O'Brien;H Duncan;G Kirsh;V Allen

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

    Michelle L. O’Donoghue;Sergio Fazio;Robert P. Giugliano;Erik S.G. Stroes

  • Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

    Marc P. Bonaca;Patrice Nault;Robert P. Giugliano;Anthony C. Keech

  • Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

    Russell Scott;Richard O'Brien;Greg Fulcher;Chris Pardy

  • Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

    AD Sniderman;CD Furberg;A Keech;JE Roeters van Lennep

  • Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

    Robert P. Giugliano;Terje R. Pedersen;Jeong Gun Park;Gaetano M. De Ferrari

  • HMG-COENZYME A REDUCTASE INHIBITION, TYPE 2 DIABETES, AND BODYWEIGHT: EVIDENCE FROM GENETIC ANALYSIS AND RANDOMISED TRIALS

    D Swerdlow;D Preiss;A D Hingorani;N Sattar

Frequent Co-Authors

Alicia J. Jenkins
Alicia J. Jenkins University of Sydney
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Robert P. Giugliano
Robert P. Giugliano Brigham and Women's Hospital
John Simes
John Simes University of Sydney
Val Gebski
Val Gebski University of Sydney
Terje R. Pedersen
Terje R. Pedersen Oslo University Hospital
Peter S. Sever
Peter S. Sever Imperial College London
Andrew Tonkin
Andrew Tonkin Monash University
Philip J. Barter
Philip J. Barter University of New South Wales
Rory Collins
Rory Collins University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but not pursuing a traditional MD, several online degrees and pathways offer exciting career options. Programs such as asn to nurse practitioner programs allow registered nurses to advance their qualifications, becoming nurse practitioners and expanding their scope of practice.

Students passionate about wellness and preventive care might consider the best online nutrition programs. These bachelor’s degrees focus on the science of nutrition and open doors to roles such as dietitian, health coach, or nutritionist.

For those interested in the administrative side of healthcare, an online mha programs (Master of Health Administration) can prepare graduates for leadership roles within hospitals, clinics, and public health organizations.

Additionally, registered nurses looking to elevate their qualifications without required onsite training can explore rn to bsn with no clinicals options — allowing for greater educational flexibility while improving job prospects.

These online pathways can help you build a fulfilling healthcare career, using flexible, accredited programs to suit your goals.

Best Scientists Citing Anthony C. Keech

Trending Scientists